DEVELOPING: Trump's Comments Spark New Momentum in Tylenol Maker Lawsuits

Breaking News: Trump's Comments Fuel New Momentum in Tylenol Lawsuits President Donald Trump's remarks last Monday linking Tylenol to autism have sparked a surge in interest from potential plaintiffs, with one law firm reporting over 1,000 new inquiries this week. The comments were made during a meeting with health officials, including the FDA commissioner and HHS Secretary. The influx of calls comes as lawsuits against Johnson & Johnson, the maker of Tylenol, continue to unfold. Attorney Ashley Keller, representing patients who claim they were harmed by the drug, says his firm is now "overwhelmed" with new requests for information. Background: The lawsuits allege that Tylenol's active ingredient, acetaminophen, causes autism and other neurological disorders in children. While Trump's comments have added fuel to the fire, it remains unclear whether they will ultimately sway the outcome of these cases. The current status of the lawsuits is uncertain, with no immediate developments expected in the coming days. However, the increased interest from potential plaintiffs suggests that this story is far from over. This is a developing story and will be updated as more information becomes available. *This is a developing story. Updates will be provided as more information becomes available. Based on reporting from Npr.*